Table 3 Reference groups timing and launch
Site 1 | Site 2 | |
|---|---|---|
Meeting 1 | ||
Date of meeting | 29/07/2013 | 01/09/2013 |
Meeting structure | 3 sub-groups established for each cancer pathway Chaired by Discovery research lead, 1 PPI member | 3 sub-groups established for each cancer pathway Chaired by local stakeholder 1 observer from National Cancer Action Team, 2 PPI members and 2 members of Discovery research team |
Post-meeting actions/activity | Discovery research team collate minutes and design pathways | Local reference group members action the pathway design |
Meeting 2 | ||
Date of meeting | 11/11/2013 | 13/11/2013 |
Meeting structure | No sub-groups – pathway changes reviewed by full reference group Chaired by Discovery research team lead Significant change in membership/attendance | No sub groups – pathway changes reviewed by full reference group Chaired by local stakeholder 2 Discovery researchers present |
Meeting outcome | Pathways presented by Discovery research team not accepted by reference group and required further work | New pathways considered and accepted with minor amendments agreed prior to implementation |
Post-meeting actions/activity | Discovery team liaise with clinical leads from reference group to redraw pathways | Local reference group members amend pathways |
Meeting 3 | ||
Date of meeting | 21/01/2014 | N/A – pathway design completed |
Meeting structure | No sub-groups – pathway changes reviewed by full reference group Chaired by Discovery research team lead Significant change in membership | |
Meeting outcome | Pathways submitted by Discovery team were not fully accepted by reference group; further work required | |
Post-meeting actions/activity | Discovery team liaise with clinical leads from reference group to redraw pathways 2 meetings with colorectal sub-group failing to reach agreement | |
Meeting 4 | ||
Date of meeting | 11/03/2014 | N/A – pathway design completed |
Meeting structure | Pathway changes reviewed by full reference group Chaired by Discovery researcher | |
Meeting outcome | Lung and pancreas pathways subject to further amendment and tentatively agreed No agreement on colorectal pathway | |
Launch and promotion of modified cancer pathways | ||
Launch meeting date | 01/05/2014 | 14/02/2014 |
Meeting details | 8 GPs in attendance No protected GP time, i.e. GPs attending in their own time Discovery team lead with support from clinical reference group members | ~230 GPs attended Protected time for GPs as part of ‘time in time out’ training day Pathways presented by reference group team Short intro from Discovery researcher |